Alger Mid Cap Focus Fund Class I (AFOIX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.46: the stock has moved about 46% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAlger Mid Cap Focus Fund Class I (AFOIX) trades at $23.72. Alger Mid Cap Focus Fund Class I is a non-diversified fund that invests primarily in mid-cap companies, with a focus on the healthcare and software industries. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for AFOIX: AFOIX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Alger Mid Cap Focus Fund Class I (AFOIX) Financial Services Profile
Alger Mid Cap Focus Fund Class I (AFOIX) is a non-diversified fund focusing on mid-cap equity securities, particularly within the Health Care and Software sectors. With at least 25% of its assets in these industries, AFOIX seeks long-term capital appreciation through strategic investments in specific growth areas.
What Is the Investment Thesis for AFOIX?
Alger Mid Cap Focus Fund Class I presents an investment opportunity for those seeking exposure to mid-cap companies with a focus on the healthcare and software sectors. The fund's strategy of concentrating investments in these high-growth areas could lead to significant capital appreciation. However, the non-diversified nature of the fund increases its volatility and risk profile. A key value driver is the potential for outperformance in the selected sectors, driven by innovation and increasing demand for healthcare and technology solutions. The fund's beta of 1.46 suggests higher volatility compared to the broader market. Investors may want to evaluate their risk tolerance and investment horizon when evaluating AFOIX.
Based on FMP financials and quantitative analysis
AFOIX Key Highlights
The fund invests at least 80% of its net assets in equity securities of mid-cap companies.
- At least 25% of the fund's total assets are invested in Health Care Equipment & Supplies, Health Care Technology, Biotechnology, Life Sciences Tools & Services, and/or Software industries.
- The fund is non-diversified, allowing for concentrated investments in specific companies and sectors.
- The fund has a beta of 1.46, indicating higher volatility compared to the market.
- The fund does not offer a dividend, focusing instead on capital appreciation.
Who Are AFOIX's Competitors?
AFOIX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ARTLX Artisan Value Fund Inv Shs | $16.03 | 0.00% | $284M | — |
| FNORX Fidelity Investment Trust - Fidelity Nordic Fund | $69.10 | +1.22% | $340M | — |
| PFPFX Poplar Forest Partners Fund Class A | $64.34 | +0.16% | $368M | — |
| PRCPX T. Rowe Price Credit Opportunities Fund, Inc. | $7.72 | +0.26% | $390M | — |
| PRJPX T. Rowe Price Japan | $16.60 | +0.79% | $338M | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AFOIX's Key Strengths?
Focus on high-growth sectors like healthcare and software.
- Potential for significant capital appreciation.
- Experienced management team.
- Non-diversified strategy allows for concentrated investments.
What Are AFOIX's Weaknesses?
Non-diversified nature increases volatility.
- Sector-specific focus limits investment opportunities.
- Reliance on specific sectors exposes the fund to sector-specific risks.
- No dividend payout may deter some investors.
What Are the Key Risks for AFOIX?
Economic downturn impacting healthcare and software spending, leading to reduced revenue and earnings for companies in these sectors.
- Regulatory changes affecting healthcare and technology companies, such as drug pricing regulations or data privacy laws, impacting their profitability and growth prospects.
- Market volatility impacting mid-cap stocks, leading to fluctuations in the fund's net asset value (NAV).
- Competition in the asset management industry, putting pressure on management fees and potentially impacting the fund's profitability.
What Are AFOIX's Competitive Advantages?
- Expertise in selecting mid-cap companies in specific sectors.
- Established track record in asset management.
- Focus on high-growth industries like healthcare and software.
What Does AFOIX Do?
Alger Mid Cap Focus Fund Class I is a non-diversified fund managed with the objective of long-term capital appreciation. The fund strategically invests at least 80% of its net assets, alongside any borrowings for investment purposes, in the equity securities of mid-cap companies. These are generally defined as companies falling within a specific market capitalization range that aligns with the fund's investment mandate. Furthermore, the fund emphasizes investments in specific high-growth sectors, allocating at least 25% of its total assets under normal market conditions to companies operating within Health Care Equipment & Supplies, Health Care Technology, Biotechnology, Life Sciences Tools & Services, and Software. This concentration allows for a focused approach within industries demonstrating significant growth potential. The fund's non-diversified status means it can invest a significant portion of its assets in a smaller number of companies, potentially leading to higher volatility but also greater potential returns. Alger Mid Cap Focus Fund Class I operates primarily within the United States, targeting companies listed on major exchanges.
What Products and Services Does AFOIX Offer?
- Invests in equity securities of mid-cap companies.
- Focuses on companies in Health Care Equipment & Supplies.
- Targets companies in Health Care Technology.
- Allocates funds to companies in Biotechnology.
- Invests in companies in Life Sciences Tools & Services.
- Includes Software companies in its portfolio.
How Does AFOIX Make Money?
- Generates revenue through management fees based on assets under management (AUM).
- Aims to achieve capital appreciation through strategic investments.
- Focuses on specific sectors to maximize potential returns.
What Industry Does AFOIX Operate In?
Alger Mid Cap Focus Fund Class I operates within the asset management industry, focusing on mid-cap companies in high-growth sectors like healthcare and software. The asset management industry is characterized by intense competition, with firms vying for investor capital. Market trends include the increasing demand for specialized investment strategies and the growing importance of technology in asset management. Competitors include firms offering similar mid-cap focused funds, such as ARTLX, FNORX, PFPFX, PRCPX, and PRJPX. The fund's focus on specific sectors differentiates it from broader market index funds.
Who Are AFOIX's Key Customers?
- Individual investors seeking mid-cap exposure.
- Institutional investors looking for sector-specific investments.
- Retirement funds aiming for long-term growth.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved +4.0%.
AFOIX Financials
Bull Case vs Bear Case
Bull Case
- Focus on high-growth sectors like healthcare and software.
- Potential for significant capital appreciation.
- Experienced management team.
- Non-diversified strategy allows for concentrated investments.
Bear Case
- Non-diversified nature increases volatility.
- Sector-specific focus limits investment opportunities.
- Reliance on specific sectors exposes the fund to sector-specific risks.
- No dividend payout may deter some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
AFOIX Latest News
No recent news available for AFOIX.
AFOIX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AFOIX.
Price Targets
Wall Street price target analysis for AFOIX.
AFOIX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AFOIX; grades run from A+ (80-100) to F (below 30).
What Investors Ask About Alger Mid Cap Focus Fund Class I (AFOIX) — Financials
What are the main risks for AFOIX?
The primary risks for Alger Mid Cap Focus Fund Class I stem from its non-diversified nature and sector concentration. Investing heavily in healthcare and software exposes the fund to sector-specific downturns and regulatory changes.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and is intended for informational purposes only.
- Investment decisions should be made after consulting with a qualified financial advisor.